Compagnie Financière Richemont SA (LON:0QMU)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	73,016	79,062	70,928	73,795	55,688	39,491
Market Cap Growth	11.47%	11.47%	-3.89%	32.52%	41.01%	58.08%
Enterprise Value	69,855	77,647	69,462	73,017	56,106	40,630
Last Close Price	126.05	134.47	117.95	122.18	90.88	62.81
PE Ratio	31.73	34.35	35.15	268.46	31.77	35.63
PS Ratio	4.08	4.42	4.03	4.21	3.94	3.53
PB Ratio	3.94	4.26	4.02	4.42	3.32	2.59
P/TBV Ratio	4.22	4.57	4.32	4.67	4.69	3.87
P/FCF Ratio	25.65	27.77	21.72	23.12	16.97	16.37
P/OCF Ratio	19.64	21.27	17.68	18.71	14.21	14.40
EV/Sales Ratio	3.67	4.34	3.94	4.17	3.96	3.63
EV/EBITDA Ratio	12.94	17.93	14.83	14.50	14.80	21.98
EV/EBIT Ratio	17.20	20.66	16.73	16.34	17.55	32.09
EV/FCF Ratio	24.54	27.28	21.27	22.88	17.09	16.84
Debt / Equity Ratio	0.59	0.59	0.79	0.83	0.76	0.76
Debt / EBITDA Ratio	2.19	2.19	2.62	2.43	2.90	4.80
Debt / FCF Ratio	3.86	3.86	4.28	4.32	3.87	4.80
Asset Turnover	0.51	0.51	0.49	0.49	0.45	0.40
Inventory Turnover	0.83	0.83	0.87	0.88	0.83	0.82
Quick Ratio	1.89	1.89	1.80	1.61	1.71	1.77
Current Ratio	2.90	2.90	2.65	2.47	2.42	2.61
Return on Equity (ROE)	17.58%	17.58%	19.26%	20.12%	12.98%	7.34%
Return on Assets (ROA)	6.71%	6.71%	7.27%	7.86%	6.28%	2.82%
Return on Capital (ROIC)	7.76%	7.76%	8.47%	9.13%	7.12%	3.17%
Return on Capital Employed (ROCE)	14.40%	14.40%	15.70%	17.80%	12.80%	5.50%
Earnings Yield	3.15%	2.91%	2.84%	0.37%	3.15%	2.81%
FCF Yield	3.90%	3.60%	4.60%	4.32%	5.89%	6.11%
Dividend Yield	1.77%	1.95%	2.05%	1.81%	2.04%	2.45%
Payout Ratio	62.16%	62.16%	62.66%	409.41%	50.19%	40.66%
Buyback Yield / Dilution	-1.64%	-1.64%	-0.47%	-0.40%	-1.38%	0.03%
Total Shareholder Return	0.13%	0.31%	1.58%	1.41%	0.67%	2.49%

Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.